# CoTherix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cotherix

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Total disclosed funding: $65M
- Latest round: Series C (Oct 14, 2003)
- Investors on record: 8

## About

Founded in 2000, CoTherix engages in biopharmaceutical operations. The company focuses on developing and commercializing therapeutic products.

## Funding rounds

- Series C, Oct 14, 2003, $55M — Alta Partners, Frazier Healthcare Partners, Sofinnova Partners, Spray Venture Partners, BioAsia Investments, TWP Private Wealth Management, MPM BioImpact
- Series B, Jun 1, 2001, $9M — Alta Partners, Sofinnova Investments, BioAsia Investments
- Series A, Feb 1, 2000, $1.3M — Spray Venture Partners

## Investors

- Spray Venture Partners (https://capitalatlas.ai/funds/spray-venture-partners) — Series A, Series C
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series B, Series C
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series C
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series C
- TWP Private Wealth Management (https://capitalatlas.ai/funds/twp-private-wealth-management) — Series C
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C